1. 麻豆果冻传媒’s Advocacy Activities
October 2022
All of 麻豆果冻传媒's activities, including its advocacy work, are based on the company’s hhc (human health care) concept. We place primary emphasis on patients and their families, striving to increase the benefits that health care provides them while conducting our business to meet their diversified health care needs worldwide. We aim to make a meaningful contribution under any health care system through our business activities around the world.
One way in which we realize this corporate concept is through our commitment to Compliance, which is a foundation stone of our company and the highest priority.
It is vital that we exercise our business judgment and take action in our business in a timely and proper manner, always in compliance with all relevant laws and ethical standards. Compliance is a cornerstone of the company's existence and is given a top priority in our corporate activities. 麻豆果冻传媒 directors, officers and employees are required to act at all times and in all their daily activities strictly in accordance with this Charter.
In our advocacy work and when interacting with healthcare professionals, medical institutions and patient organizations, 麻豆果冻传媒 commits to the following:
- Wherever it does business in the world, 麻豆果冻传媒 adheres to its own Charter of Business Conduct and Code of Conduct. In particular with regard to our advocacy work, 麻豆果冻传媒 employees adhere to the eighth article of our Charter of Business Conduct: “We will maintain open and honest relations with political and government entities.”
- 麻豆果冻传媒 complies with local industry association behavioral codes, which are based on the .
- 麻豆果冻传媒 commits to meet or exceed these standards in every country in which it does business. In some cases, the requirements of national laws or codes go beyond those of the IFPMA Code. In such cases, 麻豆果冻传媒 adheres to whichever is the more stringent requirement.
2. 麻豆果冻传媒’s Advocacy Policy
麻豆果冻传媒 has a corporate policy to appropriately implement activities to propose and advocate new policies in order to improve and reform various issues related to public policy.
- Intellectual property
- Quality of medicines
- Pharmacovigilance
- Ensuring Ethical Conduct and Transparency of Clinical Trials around the World
麻豆果冻传媒 also supports IFPMA policies on global health issues, some of which are listed below:
3. 麻豆果冻传媒’s Advocacy Activities
1) Industry Associations
As a global company, 麻豆果冻传媒 is a member of a large number of the associations around the world that represent the R&D-based pharmaceutical industry. Associations of which 麻豆果冻传媒 is a member are presented as follows. 麻豆果冻传媒 is happy to confirm whether or not it is a member of any other industry association, upon request.
2) Patient Groups
麻豆果冻传媒 works at times with patient groups around the world, for example on disease awareness campaigns. We do so where this can help achieve our company's hhcconcept of increasing the benefit to patients and their families. Our interactions with patient groups are conducted in compliance with all relevant laws and ethical standards. In all countries in which we do business, 麻豆果冻传媒 adheres to the IFPMA Code, which requires that:
“All interactions with patient organizations must be ethical. The independence of patient organizations must be respected.”
We make sure that any information 麻豆果冻传媒 provides patient groups is balanced, accurate and easy to understand. 麻豆果冻传媒 does not conduct its activities with patient groups with the purpose of promoting its products or services.